Is Harpoon Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: HARP) stock is to Hold HARP stock.
Out of 3 analysts, 0 (0%) are recommending HARP as a Strong Buy, 1 (33.33%) are recommending HARP as a Buy, 2 (66.67%) are recommending HARP as a Hold, 0 (0%) are recommending HARP as a Sell, and 0 (0%) are recommending HARP as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year HARP price target, the average HARP price target is $3.00, with the highest HARP stock price forecast at $4.00 and the lowest HARP stock price forecast at $2.00.
On average, Wall Street analysts predict that Harpoon Therapeutics's share price could reach $3.00 by Dec 14, 2023. The average Harpoon Therapeutics stock price prediction forecasts a potential upside of 359.42% from the current HARP share price of $0.65.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.